 |
|
Daily Cost of β-Adrenergic Blocker Therapy
William C. Stewart, MD;
Cheryl Sine;
Elin Cate;
George E. Minno, PhD;
Hurshell H. Hunt, PhD
Arch Ophthalmol. 1997;115(7):853-856.
Abstract
| |
Objective
To evaluate the daily cost of β-blocker therapy among commercially available products.
Methods
Ten different β-adrenergic blocker preparations, each in 10-mL bottles (except Timoptic-XE [Merck brand of timolol maleate gel-forming solution], which was in a 5-mL bottle), were acquired from a local pharmacy. Each of 10 subjects dispensed 10 drops from each bottle onto an analytical scale. The mean drop volume for each preparation was then calculated. The fill volume of each bottle and the amount of each medicine that was wasted upon dispensing also were determined. Additionally, 60 pharmacies in the United States were randomly chosen to determine the average cost of each preparation studied. Based on all data obtained, an average daily cost of each medicine was calculated.
Results
The generic formulation of timolol maleate (Falcon) ($0.55) and Betimol (Ciba Vision Ophthalmics brand of timolol hemihydrate) ($0.57) demonstrated the lowest cost per day of therapy. In contrast, Betoptic-S (Alcon brand of betaxolol hydrochloride) ($1.60) and Betagan (Allergan brand of levobunonol hydrochloride) ($1.35) had the highest daily cost of therapy. Ocupress (Otsuka America brand of carteolol hydrochloride) had the smallest drop volume (31 µL) and Timoptic-XE had the highest (49 pL). Most preparations were close to their stated bottle fill volume. The amount of wasted medicine varied and was least with Ocupress (27%) and greatest with Betoptic-S (54%). The mean pharmacy price for a 10-mL bottle was lowest for OptiPranolol (Bausch & Lomb brand of metipranolol) ($25.51) and Betimol ($28.28); Betoptic-S ($44.80) and Betagan ($43.67) were the most expensive.
Conclusion
Although all commercially available β-adrenergic blockers effectively lower intraocular pressure, one differential factor between medicines is cost, which may be influenced by the price at the pharmacy, volume of medication per bottle, drop size, and medicine wastage.
Author Affiliations
From the Pharmaceutical Research Corporation, Charleston, SC (Dr Stewart and Mss Sine and Cate); the Department of Ophthalmology, University of South Carolina Medical School, Columbia (Dr Stewart), Ciba Vision Ophthalmics, Duluth, Ga (Dr Minno); and the Department of Biometry and Epidemiology, Medical University of South Carolina, Charleston (Dr Hunt).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cost-effectiveness of low dose corticosteroids versus non-steroidal anti-inflammatory drugs and COX-2 specific inhibitors in the long-term treatment of rheumatoid arthritis
Bae et al.
Rheumatology (Oxford) 2003;42:46-53.
ABSTRACT
| FULL TEXT
Cost of {beta}-Blocker Therapy
Zimmerman
Arch Ophthalmol 1997;115:914-914.
ABSTRACT
|
